---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "sOGe6ZgbcV0MporlrJ+jxK9qKTPdjff7LFkPVvKee7A1n/A0uKla8j/Y3WLlPT8jIdLYTv0U2eiOblYNzzvtaCLEZdoVTfqlpePF7caBvuuAud6eX9f3CHYbsO7zbIAOl8xaLrkMmYICQRrCoZ+Kl9tw0mVsnUQuKsyX3jbKFQbq+S8gsyr7KwISczVk1tlm5wTDOW5MwchEQRey0nLJSU+WwEUxHpTmFMZYN+ZPo+XWIFhXGQRJNjgmZ/wBuw6A72suXVqNYBXI9dMxI5vFGhAlpIti4V+LLfFZbDBfXm/kaZb/mHmASfhqDfQOnj5H2307lp5RYbUoECAUzIakA0KEr/0YjWIwwDOI/bgeC6k=;ybdovhKUH1hyzqsbHE9xIQ=="
---

